drugset

drugset / Trial / NCT04629404

A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients

NCT04629404 ↗

Phase 1 Completed 32 enrolled Luye Pharma Group Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients

Timeline

Start: 2018-11-05
Primary completion: 2019-03-14
Completion: 2019-03-14

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	LY03003	Unknown	56 mg	—

Indications